Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29 Stomach Neoplasms 25 Rectal Neoplasms 25 Colonic Neoplasms 13 Neoplasms 3 Neoplasm Metastasis 3 Adenocarcinoma 3 Gastrointestinal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Turcot syndrome 1 Recurrence 1 Rcctal Cancer 1 Peripheral Nervous System Diseases 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Locally Advanced Gastric Cancer 1 Locally Advanced Colorectal Cancer 1 Intestinal Neoplasms 1 HER2-positive Locally Advanced Resectable Gastric Cancer 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Diseases 1 Gastric Cancer Stage 1 Gastric Adenocarcinoma 1 Esophageal Neoplasms 1 Digestive System Diseases 1 Colorectal Cancer Metastatic 1 Colonic Diseases 1 Carcinoma 1 Adenocarcinoma of the Lower Rectum 1

Interventions

Bevacizumab 19 Capecitabine 15 Oxaliplatin 11 Irinotecan 11 Cetuximab 11 Fluorouracil 10 Leucovorin 8 aflibercept 7 Panitumumab 6 trifluridine tipiracil drug combination 4 Nivolumab 4 sintilimab 3 regorafenib 3 Ipilimumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Folfox protocol 2 Drug Therapy 2 tremelimumab 1 spartalizumab 1 raltitrexed 1 pembrolizumab 1 monoclonal antibody YYB-101 1 masitinib 1 irinotecan sucrosofate 1 glucopyranosyl lipid-A 1 folfirinox 1 durvalumab 1 camrelizumab 1 balstilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × XELOX × Clear all

NCT01910610 2024-03-12

STRATEGIC-1

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡